VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 39.37% | -7.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 32.04% | -14.84% | |||
| Operating Income | -43.16% | 21.46% | |||
| Income Before Tax | -39.26% | 18.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -39.26% | 11.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -39.26% | 11.65% | |||
| EBIT | -43.16% | 21.46% | |||
| EBITDA | -43.18% | 21.50% | |||
| EPS Basic | -39.02% | 12.77% | |||
| Normalized Basic EPS | -38.46% | 18.75% | |||
| EPS Diluted | -39.02% | 12.77% | |||
| Normalized Diluted EPS | -38.46% | 18.75% | |||
| Average Basic Shares Outstanding | 0.70% | 0.79% | |||
| Average Diluted Shares Outstanding | 0.70% | 0.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||